Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NBIX | C | Neurocrine Biosciences, Inc. | 1.39 | |
LDOS | C | Leidos Holdings, Inc. | 1.57 | |
VNDA | C | Vanda Pharmaceuticals Inc. | 0.82 | |
VCNX | C | Vaccinex, Inc. | -2.96 | |
QURE | C | uniQure N.V. | 2.54 | |
MEDP | D | Medpace Holdings, Inc. | 4.82 | |
ATRA | D | Atara Biotherapeutics, Inc. | -0.66 | |
ALNY | D | Alnylam Pharmaceuticals, Inc. | -0.80 | |
FGEN | D | FibroGen, Inc | 10.63 | |
MEIP | D | MEI Pharma, Inc. | 0.36 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Biotechnology
Cancer
Clinical Medicine
Immunology
Monoclonal Antibodies
Antibody Drug Conjugate
Autoimmune Disease
Biology
Breast Cancer
Cancer Treatment
Clinical Research
Colitis
Immunotherapy
Life Sciences
Ovarian Cancer
Solid Tumors
Treatment Of Breast Cancer
Ulcer
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | C | BioShares Biotechnology Products Fund | 8.59 | |
EKG | B | First Trust Nasdaq Lux Digital Health Solutions ETF | 6.03 | |
PSCH | C | PowerShares S&P SmallCap Health Care Portfolio | 5.61 | |
TMFS | A | Motley Fool Small-Cap Growth ETF | 4.73 | |
HELX | D | Franklin Genomic Advancements ETF | 4.7 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Organ Systems
Pain
Autoimmune Disease
Cancer
Central Nervous System Disorders
Monoclonal Antibodies
Monoclonal Antibody
Nervous System Disorders
Oncology
Pulmonology
Rare Diseases
Alzheimer's Disease
Antibodies
Antibody Drug Conjugate
Antidepressants
Asthma
Back Pain
Biomaterial
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles